HN2006023741A - " formulaciones de liberacion prolongada de principios activos de zolpidem hemitartrato" - Google Patents
" formulaciones de liberacion prolongada de principios activos de zolpidem hemitartrato"Info
- Publication number
- HN2006023741A HN2006023741A HN2006023741A HN2006023741A HN2006023741A HN 2006023741 A HN2006023741 A HN 2006023741A HN 2006023741 A HN2006023741 A HN 2006023741A HN 2006023741 A HN2006023741 A HN 2006023741A HN 2006023741 A HN2006023741 A HN 2006023741A
- Authority
- HN
- Honduras
- Prior art keywords
- ingredient
- prolonged release
- formulation
- zolpidem hemitartrate
- active
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Anesthesiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
RESUMEN ACTUAL: FORMULACION DE LIBERACION PROLONGADA QUE PUEDE SER USADA CON EL INGREDIENTE ACTIVO ZOLPIDEM HEMITARTRATO, COMPRENDIENDO UN EXCIPIENTE MATRICIAL BASADO EN UN POLIMERO HIDROFILICO, EL EXCIPIENTE MATRICIAL CONTENIENDO UNA DOSIS DADA DE INGREDIENTE ACTIVO, CARACTERIZADO EN QUE COMPRENDE UNO O MAS AGENTES ACIDIFICANTES EN LA FORMA DE UNA SAL DE UN ACIDO ORGANICO SIENDO LA SAL ACIDA DEL AGENTE ACIDIFICANTE TARTRATO MONO POTASICO, TARTRATO MONO SODICO, CITRATO MONOSODICO, CITRATO BISODICO, Y/O SUS MEXCLAS. RESUMEN ANTERIOR: LA INVENCION SE REFIER A UNA FORMULACION NUEVA PARA UNA LIBERACION PROLONGADA DE UN PRINCIPIO ACTIVO QUE PRESENTA UNA SOLUBILIDAD DEPENDIENTE DEL PH. LA FORMULACION DE LA INVENCION COMPRENDE UN EXCIPIENTE MATRICIAL A BASE DE POLIMERO HIDROFILO QUE CONTIENE UNA DOSIS DETERMINADA DEL PRINCIPIO ACTIVO, Y TAMBIEN COMPRENDE UNO O VARIOS AGENTES ACIDIFICANTES EN FORMA DE UNA SAL ACIDA DE UN ACIDO ORGANICO.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0506539A FR2887455B1 (fr) | 2005-06-28 | 2005-06-28 | Formulation a liberation prolongee de principes actifs de medicaments |
Publications (1)
Publication Number | Publication Date |
---|---|
HN2006023741A true HN2006023741A (es) | 2011-05-31 |
Family
ID=35708770
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HN2006023741A HN2006023741A (es) | 2005-06-28 | 2006-06-27 | " formulaciones de liberacion prolongada de principios activos de zolpidem hemitartrato" |
Country Status (31)
Country | Link |
---|---|
US (1) | US20080089936A1 (es) |
EP (1) | EP1904037A1 (es) |
JP (1) | JP2008546830A (es) |
KR (1) | KR101387839B1 (es) |
CN (1) | CN101217943B (es) |
AR (1) | AR057410A1 (es) |
AU (1) | AU2006264856B2 (es) |
BR (1) | BRPI0612990A2 (es) |
CA (1) | CA2611125A1 (es) |
CR (1) | CR9567A (es) |
DO (1) | DOP2006000144A (es) |
EA (1) | EA013745B1 (es) |
EC (1) | ECSP078010A (es) |
FR (1) | FR2887455B1 (es) |
GT (1) | GT200600275A (es) |
HK (1) | HK1122731A1 (es) |
HN (1) | HN2006023741A (es) |
IL (1) | IL187901A0 (es) |
MA (1) | MA29560B1 (es) |
MX (1) | MX2007016238A (es) |
MY (1) | MY150069A (es) |
NO (1) | NO20080420L (es) |
NZ (1) | NZ564069A (es) |
PA (1) | PA8682701A1 (es) |
PE (1) | PE20070098A1 (es) |
TN (1) | TNSN07438A1 (es) |
TW (1) | TWI446934B (es) |
UA (1) | UA91553C2 (es) |
UY (1) | UY29637A1 (es) |
WO (1) | WO2007003746A1 (es) |
ZA (1) | ZA200711035B (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2090297A1 (en) * | 2008-02-13 | 2009-08-19 | Boehringer Ingelheim International GmbH | Formulations of flibanserin |
BR112014006124A2 (pt) * | 2011-09-14 | 2017-04-11 | Pozen Inc | dosagem faseada de clopidogrel |
IT201700011337A1 (it) * | 2017-02-02 | 2018-08-02 | S I I T S R L Servizio Int Imballaggi Termosaldanti | Compressa multistrato per la somministrazione di magnesio |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2655266B1 (fr) * | 1989-12-05 | 1992-04-03 | Smith Kline French Lab | Compositions pharmaceutiques a base de cimetidine. |
DE59303759C5 (de) * | 1992-01-17 | 2009-04-09 | Alfatec-Pharma Gmbh | Wirkstoff-enthaltende festkörper mit einem gerüst aus hydrophilen makromolekülen und verfahren zu ihrer herstellung |
EP1005863A1 (en) * | 1998-12-04 | 2000-06-07 | Synthelabo | Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof |
AU3469100A (en) * | 1999-01-05 | 2000-07-24 | Copley Pharmaceutical Inc. | Sustained release formulation with reduced moisture sensitivity |
EP1064937A1 (en) * | 1999-06-28 | 2001-01-03 | Sanofi-Synthelabo | Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof |
JP4933033B2 (ja) * | 2003-03-17 | 2012-05-16 | 武田薬品工業株式会社 | 放出制御組成物 |
WO2005044199A2 (en) * | 2003-11-05 | 2005-05-19 | Santarus, Inc. | Combination of proton pump inhibitor and sleep aid |
-
2005
- 2005-06-28 FR FR0506539A patent/FR2887455B1/fr not_active Expired - Fee Related
-
2006
- 2006-06-23 PA PA20068682701A patent/PA8682701A1/es unknown
- 2006-06-26 UA UAA200800914A patent/UA91553C2/ru unknown
- 2006-06-26 AU AU2006264856A patent/AU2006264856B2/en not_active Ceased
- 2006-06-26 MX MX2007016238A patent/MX2007016238A/es active IP Right Grant
- 2006-06-26 KR KR1020077030484A patent/KR101387839B1/ko active IP Right Grant
- 2006-06-26 EP EP06778663A patent/EP1904037A1/fr not_active Withdrawn
- 2006-06-26 BR BRPI0612990-0A patent/BRPI0612990A2/pt not_active Application Discontinuation
- 2006-06-26 EA EA200800150A patent/EA013745B1/ru not_active IP Right Cessation
- 2006-06-26 NZ NZ564069A patent/NZ564069A/en not_active IP Right Cessation
- 2006-06-26 DO DO2006000144A patent/DOP2006000144A/es unknown
- 2006-06-26 WO PCT/FR2006/001466 patent/WO2007003746A1/fr active Application Filing
- 2006-06-26 ZA ZA200711035A patent/ZA200711035B/xx unknown
- 2006-06-26 MY MYPI20063017A patent/MY150069A/en unknown
- 2006-06-26 CN CN2006800231372A patent/CN101217943B/zh active Active
- 2006-06-26 CA CA002611125A patent/CA2611125A1/fr not_active Abandoned
- 2006-06-26 JP JP2008518906A patent/JP2008546830A/ja active Pending
- 2006-06-27 HN HN2006023741A patent/HN2006023741A/es unknown
- 2006-06-27 GT GT200600275A patent/GT200600275A/es unknown
- 2006-06-27 AR ARP060102755A patent/AR057410A1/es unknown
- 2006-06-28 PE PE2006000753A patent/PE20070098A1/es active IP Right Grant
- 2006-06-28 TW TW095123267A patent/TWI446934B/zh not_active IP Right Cessation
- 2006-06-29 UY UY29637A patent/UY29637A1/es unknown
-
2007
- 2007-11-26 TN TNP2007000438A patent/TNSN07438A1/en unknown
- 2007-12-03 US US11/949,291 patent/US20080089936A1/en not_active Abandoned
- 2007-12-04 IL IL187901A patent/IL187901A0/en unknown
- 2007-12-06 CR CR9567A patent/CR9567A/es unknown
- 2007-12-13 EC EC2007008010A patent/ECSP078010A/es unknown
- 2007-12-24 MA MA30501A patent/MA29560B1/fr unknown
-
2008
- 2008-01-22 NO NO20080420A patent/NO20080420L/no not_active Application Discontinuation
- 2008-12-29 HK HK08114006.5A patent/HK1122731A1/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2539861T3 (es) | Formulaciones en emulsión de clevidipina que contienen agentes antimicrobianos | |
ES2557303T3 (es) | Agente terapéutico para la estenosis del canal espinal | |
AR067309A1 (es) | Formulaciones farmaceuticas que contienen derivados de acido lipoico | |
UY36542A (es) | Formulaciones farmacéuticas para anticuerpos anti-tnf-alfa | |
NO20080220L (no) | Formuleringer med hoy medikament belastning og doseringsformer | |
AR063471A1 (es) | Formulaciones para administracion parenteral de compuestos y sus usos | |
ES2525497T3 (es) | Composiciones farmacéuticas de liberación controlada que comprenden un éster de ácido fumárico | |
AR059723A2 (es) | Composicion de altas dosis de ibandronato | |
ATE493973T1 (de) | Irbesartan enthaltende pharmazeutische zusammensetzung | |
PE20110642A1 (es) | Formulaciones antifungicas topicas a base de terbinafina y compuestos similares a terbinafina y metodos de uso | |
CO6220902A2 (es) | Formulacion en polvo del valganciclovir | |
AR105203A1 (es) | Formulación oral sólida que contiene irinotecán y método de preparación de la misma | |
HN2006023741A (es) | " formulaciones de liberacion prolongada de principios activos de zolpidem hemitartrato" | |
AR067048A1 (es) | Formulaciones acuosas de acetaminofen para inyeccion. | |
TR200806300A2 (tr) | Çözünürlük artırıcı farmasötlk formulasyon | |
UY29989A1 (es) | Composiciones farmacéuticas de agentes hipnoticos de accion corta en forma de liberación modificada y los procedimientos para preparar dichas formulaciones | |
ECSP099251A (es) | Formulaciones farmacéuticas | |
AR067047A1 (es) | Formulaciones acuosas de acetaminofen para inyeccion. | |
PE20030277A1 (es) | Composicion farmaceutica que comprende 2-[5-(4-fluorofenil)-3-piridilmetilaminometil]-cromano y l-dopa | |
AR033807A1 (es) | Uso de (r)-(-)-2-[5-(4-fluorofenil)-3-piridilmetilaminometil]-cromano y de sus sales aceptables para uso fisiologico, y las composiciones farmaceuticas que contiene estos compuestos | |
PE20110923A1 (es) | Formulaciones de desintegracion rapida pre-compactadas de compuestos con baja biodisponibilidad oral | |
PE20091209A1 (es) | Sales de propionato de 3-(2,2,2-trimetilhidrazinio) | |
ES2572180T3 (es) | Formulaciones de liberación controlada que comprenden unidad(es) discreta(s) sin recubrimiento y una matriz de liberación prolongada | |
ATE530172T1 (de) | Pharmazeutische formulierungen mit clopidogrel | |
FI3737378T3 (fi) | Palonosetronisilmätipat pahoinvoinnin ja oksentelun hoitoon tai ehkäisyyn |